Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-06-22T17:09:22.846Z Has data issue: false hasContentIssue false
  • English
  • Français

45-Years Between Skin Lesions and CNS Symptoms in a Patient with Scleroderma

Published online by Cambridge University Press:  02 December 2014

Jason K. Wasserman ,
Rafael Glikstein  and
Michael Sharma
Jason K. Wasserman
Affiliation:
University of Ottawa, Ottawa, Ontario, Canada
Rafael Glikstein
Affiliation:
The Ottawa Hospital, Ottawa, Ontario, Canada Email: msharma@ottawahospital.on.ca
Michael Sharma
Affiliation:
The Ottawa Hospital, Ottawa, Ontario, Canada Email: msharma@ottawahospital.on.ca
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Canadian Journal of Neurological Sciences , Volume 39 , Issue 5 , September 2012 , pp. 686 - 687
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1.Kister, I, Inglese, M, Laxer, RM, Herbert, J.Neurologic manifestations of localized scleroderma: a case report and literature review. Neurology. 2008 Nov 4;71(19):1538–45.Google Scholar
2.Korkmaz, C, Adapinar, B, Uysal, S.Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature. South Med J. 2005Sep;98(9):940–2.CrossRefGoogle ScholarPubMed
3.Kreuter, A, Gambichler, T, Breuckmann, F, et al.Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol. 2005 Jul;141(7):847–52.Google Scholar